Find Academic Supervisors

Dr. Gema Frühbeck Martínez is a Specialist in Endocrinology and Nutrition and Professor of Nutrition and Food Science at the Faculty of Medicine, University of Navarra. She serves as Co-Director of the Obesity Department and Director of the Metabolic Research Laboratory at the University of Navarra Clinic. Her work integrates clinical practice with research on obesity pathophysiology and metabolic mechanisms. Education: Medicine and Surgery, University of Navarra (Extraordinary Doctorate Award, 1995); Postdoctoral, Medical Research Council - Dunn Clinical Nutrition Centre, University of Cambridge (Research Fellow, Royal Society). She has been part of the Multidisciplinary Obesity Diagnosis and Treatment Team since 1998, introducing body composition testing and indirect calorimetry into clinical practice. Her research spans obesity, nutrition, and metabolic disorders, supported by her role as a Registered Nutritionist from 1998. Articles were not explicitly listed in the provided text. Scientific Awards IBER Award (1996) Nutrition Society Medal (2000) López Sánchez Foundation Award (2001) Clínica Abril Research Award (2002) Best Paper Award for Obesity Surgery (2004) Doctor Laguna Serrano Award (2005) Sir David Cuthbertson Medal (2005) AMA Food and Health Award (2007) Pfizer Lifetime Achievement in Neuroendocrinology (2009) GSK Best Original Article (2009) Honorable Mention, British Medical Association Book Awards (2010) Lilly Foundation Distinguished Career Award (2011) Labs and Teams Director, Metabolic Research Laboratory, University of Navarra Clinic Co-Director, Obesity Department, University of Navarra Clinic (2015–present) Member, Multidisciplinary Obesity Diagnosis and Treatment Team (since 1998)

• Obesity
• Nutrition
• Endocrinology
• +3 more

Peyman Karami is a Postdoctoral Researcher at the Laboratory of Biomechanical Orthopedics (LBO) within École Polytechnique Fédérale de Lausanne (EPFL)'s College of Engineering . Research focuses on adhesive hydrogels for cartilage repair and orthopedic applications Investigates biomimetic stimuli (hydrostatic pressure, temperature) in chondrocyte homeostasis Develops ligin-based multifunctional hydrogels for sustainable biomedical applications Expertise in mechanobiology and thermomechanical regulation of tissue-engineered constructs Scientific Contributions: Leads 15+ publications on hydrogel technologies for cartilage regeneration, thermomechanical stimulation effects, and lignin functionalization, including breakthrough work in NIR-light photocuring , malacic trachea repair , and biomimetic temperature gradients . Current Research Trends: Prioritizes injectable adhesive hydrogels , noninvasive tissue repair , and multi-functional biomaterials that couple mechanical and biochemical cues for enhanced regeneration.

• Biomedical Engineering
• Biomechanics
• Tissue Engineering
• +3 more

Andrea Falini is a Full Professor of Neuroradiology at the Vita-Salute San Raffaele University (School of Medicine). He holds leadership roles including Head of the Neuroradiology Department at the Scientific Institute S. Raffaele Hospital and Head of the Advanced Diagnostic in Neuro-oncology Unit. His career spans clinical, academic, and administrative roles since 1991, with extensive experience in neuroradiology, neuro-oncology, and neuroimaging research. Education: MD (1986, University of Milan), PhD in Neurological Sciences (1989), and specialized training in Neurology and Radiology at leading institutions, including a visiting scholar position at UCSF (1996). Research interests focus on advanced MRI techniques, neuro-oncology, neurodegenerative diseases, and cognitive neuroscience. His work emphasizes functional MRI, diffusion tensor imaging, and clinical applications in glioma management and neurodegenerative disorders. Awarded the 1989 'De Visart' Prize and grants supporting his international collaborations. He has authored 218+ peer-reviewed articles, with an H-index of 40+, and actively contributes to academic committees and international conferences. Leadership roles include Vice-Director of the Neuroscience Division (2014–present) and coordination of the BraiMap Research Program. His academic teaching spans neuroradiology, biomedical engineering, and cognitive neuroscience courses.

• Advanced MR Techniques
• Neuro-oncology
• Degenerative Diseases
• +3 more

Xinxin Song, M.D., Ph.D., is an Assistant Professor in the Department of Surgery at the University of Texas Southwestern Medical Center. She holds a medical degree from Peking University Health Science Center and a Ph.D. from Peking Union Medical College. After post-doctoral training at the University of Pittsburgh, she became a Research Assistant Professor at Northwestern University's Feinberg School of Medicine before joining UT Southwestern in 2020. Her lab focuses on understanding mechanisms of cell death (apoptosis, ferroptosis, pH-dependent death, immunogenic cell death) and their interplay with drug resistance, tumor microenvironment, and cancer immunogenicity. Education: M.D., Health Science Center, Peking University Ph.D., Peking Union Medical College Post-doctoral Training, University of Pittsburgh School of Medicine Research Interests: Mechanisms of programmed cell death (apoptosis, ferroptosis) Drug resistance in cancer Tumor microenvironment dynamics Immunogenic cell death pathways Labs/Teams: Established her independent lab in the Department of Surgery at UT Southwestern in 2023

• Cell Death Mechanisms
• Ferroptosis
• Apoptosis
• +4 more

Shushu Huang is an Associate Research Scientist in the Department of Genetics at Yale School of Medicine. They hold a PhD from Nanjing Medical University (2023) and an MD from the same institution (2013). Their research focuses on genetic and molecular mechanisms underlying metabolic disorders, muscular dystrophies, and cardiovascular diseases. Key areas include CRISPR-based therapeutic discovery, high-throughput functional genomics, and gene therapy safety. Huang has collaborated with researchers like Monkol Lek and Carlos Fernandez-Hernando on projects involving LXR signaling, DUX4 toxicity, and MC4R variant analysis. Publications span studies on vascular biology, gene therapy outcomes, and obesity genetics. Notable work includes investigating hypercholesterolemia’s role in vascular remodeling and analyzing MC4R variants in morbid obesity. Their lab is located in the Anlyan Center, New Haven.

• Genetics
• Molecular Biology
• Gene Therapy
• +4 more

Helen Suh is a Professor at Tufts University, jointly appointed in the departments of Civil and Environmental Engineering and Community Health . As an internationally-recognized expert in air pollution health effects, she combines environmental epidemiology , exposure science , and data analytics to investigate how pollutants impact human health. Sc.D. , Harvard University (1993) M.S. , Harvard University (1990) S.B. , Massachusetts Institute of Technology (1985) Her research focuses on three areas: air pollutant impacts on cognitive performance and child development , multi-pollutant health effects , and GIS-based spatio-temporal modeling for epidemiological studies. Recent publications highlight her work on PM2.5 measurement error correction , hormonal disruptions in pregnancy , and machine learning applications in environmental health analysis. Current trends include: Advanced statistical methods for exposure assessment Multi-omics approaches to cardiometabolic health International comparative studies (e.g., Tehran, Puerto Rico) Long-term mortality analysis in Medicare populations Pollution-immune system interactions in vulnerable groups Policy-relevant modeling for air quality standards Helen Suh has served as an Associate Editor for the Journal of Exposure Science and Environmental Epidemiology and advised major U.S. and international health organizations. Her work spans over 150 publications and integrates multidisciplinary team leadership in environmental health science. Her laboratory develops large-scale data analytics tools and spatio-temporal exposure models to support population-level health research. Current projects include air pollution and aging cohorts , urban environmental noise measurement , and epigenetic responses to pollutants .

• Environmental Health
• Environmental Epidemiology
• Air Pollution
• +2 more

Roxanne Wadia, MD, holds dual roles as a Clinical Fellow in Pathology and Clinical Assistant Professor of Medicine (Medical Oncology) at Yale School of Medicine. Her expertise spans anatomic and cytopathology, with a focus on cancer diagnosis and treatment guidance. She completed her medical degree at Vanderbilt University School of Medicine (2008) and is board-certified in Anatomic Pathology (2023) and Cytopathology (2024). Dr. Wadia’s research integrates oncology, HIV/AIDS, and medical informatics, leveraging large datasets such as the VA’s Million Veterans Program to improve cancer care outcomes. She actively contributes to clinical care at Yale New Haven Hospital, the VA Connecticut Healthcare System, and the Hospital of Saint Raphael’s, emphasizing holistic patient care and interdisciplinary collaboration. Her research explores prostate cancer prognosis, HIV-related malignancies, and healthcare analytics. Key projects include developing predictive tools for nonmetastatic prostate cancer mortality and studying lung cancer surgery outcomes in HIV-positive patients. Dr. Wadia also mentors trainees in oncology and hematology, emphasizing independent clinical decision-making. She participates in the VA’s clinical training programs for medical students, residents, and fellows, fostering a balance between clinical practice and research innovation.

• Oncology
• HIV/AIDS and Cancer
• Medical Informatics
• +4 more

Prof. Yunus Yavuz, MD, is a distinguished academic in the field of General Surgery, currently affiliated with Koç University Hospital and American Hospital as a Professor. He has held faculty roles at Istanbul Bilim University (2011–2013) and Marmara University (2007–2011). His career spans advanced laparoscopic and metabolic surgery training in Norway and the Netherlands, with clinical experience in New Jersey Bariatrics and Atlantic Health Group. Education: Medical degree from University of Oslo (1997–2001), General Surgery Residency at Marmara University (1992–1997), and specialized training in Minimally Invasive Surgery & Obesity Surgery (1997–2006) at the National Center for Advanced Laparoscopic Surgery, Trondheim, Norway. Career Highlights: Professor at Koç University Hospital and American Hospital (2013–present), Lecturer at Istanbul Bilim University and Marmara University (2007–2013), and leadership in research/education at Norwegian University of Science and Technology (1997–2006). Prof. Yavuz focuses on Laparoscopic and Metabolic Surgery , with expertise in single-incision techniques and obesity-related interventions. He is a member of multiple international surgical societies, including the American Society for Metabolic and Bariatric Surgery and the European Association for Endoscopic Surgery. Key professional affiliations: American Society for Metabolic and Bariatric Surgery, International Federation for the Surgery of Obesity and Metabolic Disorders, European Association for Endoscopic Surgery and Other Interventional Techniques, Society of American Gastrointestinal Endoscopic Surgeons, Turkish Society of Obesity Surgery, Turkish Surgical Association, European Association for Translumenal Surgery, National Association of Laparoscopic and Endoscopic Surgery, Istanbul Surgical Association, and Istanbul Medical Association.

• Laparoscopic Surgery
• Obesity Surgery
• Metabolic Surgery
• +3 more

Sergio Infante, MD, is an Associate Professor in the Department of Medicine at the School of Medicine and an Assistant Professor in the Department of Pharmacy Practice at the School of Pharmacy, both at Loma Linda University. His dual appointment reflects his interdisciplinary expertise in clinical nephrology and pharmacy practice, particularly in managing patients with kidney disease and optimizing medication regimens in renal impairment. Associate Professor, Department of Medicine, School of Medicine, Loma Linda University Assistant Professor, Department of Pharmacy Practice, School of Pharmacy, Loma Linda University Dr. Infante's research focuses on nephrology, transplantation, and pharmaceutical care in chronic and critical illness. His work addresses key clinical challenges such as drug dosing in continuous renal replacement therapy, bone health in dialysis patients, outcomes in kidney transplant recipients, and mental health in end-stage renal disease. He also investigates interdisciplinary models of care to improve patient adherence and outcomes in dialysis. His recent publications (2017–2024) demonstrate consistent scholarly output across nephrology, pharmacy, and internal medicine journals. These studies include case reports, clinical research, and interdisciplinary reviews, with a strong emphasis on practical applications in patient management. Themes in his research include mineral and bone disorders in CKD, ultrafiltration strategies, post-transplant complications, and the intersection of mental health with chronic kidney disease. Dr. Infante has been actively involved in multiple research projects, including investigator roles in industry-sponsored and internally funded studies. Notably, he served as Principal Investigator (PD/PI) on a grant from LLU-GRASP (2021–2025) examining lithium use in depression and suicidal ideation among ESRD patients, indicating leadership in psychonephrology research. Evaluation of polymyxin B hemoperfusion in septic shock (EUPHRATES) – Investigator (Spectral Diagnostics Inc., 2014–2015) Assessment of kidney disease in COVID-19 patients – Investigator (LLU Dept. of Medicine, 2021) Literacy and numeracy in dialysis medication labeling – Investigator (LLU Dept. of Pharmacy, 2019) Clinical outcomes of induction therapies in transplant patients – Investigator (LLU Transplantation Institute, 2007–2015) Role of lithium in depression in ESRD – PD/PI (LLU-GRASP, 2021–2025) While no formal lab or team is explicitly mentioned, his collaborative publications and project leadership suggest active participation in multidisciplinary research teams involving nephrology, pharmacy, psychiatry, and transplantation. His future work appears to focus on mental health in renal populations, patient education, and precision dosing in critical care nephrology.

• Nephrology
• Pharmacy Practice
• Internal Medicine
• +12 more

Veerle Foulon serves as full professor and dean of the Faculty of Pharmaceutical Sciences at KU Leuven, Belgium. She leads the Unit Clinical Pharmacology and Pharmacotherapy within the Department of Pharmaceutical and Pharmacological Sciences. Her institutional leadership roles include membership in the University Council, Academic Council, and Special Academic Council as dean, alongside positions in the Board for Alumni Relations and Biomedical Sciences Group Management. Leuven Centre for Health Humanities Leuven Interdisciplinary Centre for Meaning and Lived Religion LC&Y - KU Leuven Institute for Child and Youth LIVO – KU Leuven Institute for Educational Research LKI - KU Leuven Cancer Institute Her research centers on pharmaceutical care, interdisciplinary collaboration, patient-centered care, and rational pharmacotherapy. Key focus areas include medication safety during pregnancy through the BELpREG registry, antimicrobial stewardship in Ethiopian healthcare settings, and person-centered medication optimization for elderly patients in nursing homes. She emphasizes real-world data collection and interdisciplinary approaches to address critical gaps in medication safety for vulnerable populations. Analysis of her recent publications reveals dominant themes in pregnancy medication safety (particularly via the BELpREG cohort), nursing home medication pathways, and antimicrobial resistance interventions. Her work consistently involves large-scale international collaborations across Europe and Ethiopia, addressing systemic challenges in pharmaceutical care through mixed-methods designs and registry-based studies. As principal investigator on major funded projects extending to 2028—including antimicrobial resistance initiatives in Ethiopia and pregnancy medication safety studies—she directs substantial research grants. Her leadership in interdisciplinary consortia drives innovation in medication optimization, though specific doctoral advisees are not documented in the provided materials. Current projects demonstrate strong translational focus with direct clinical implementation pathways. Embedded within multiple Leuven research institutes, she fosters cross-disciplinary collaborations through the BELpREG consortium and antimicrobial stewardship networks. Her work actively involves partnerships with Ethiopian tertiary hospitals, European pregnancy registries, and Belgian nursing home networks to develop and implement evidence-based pharmaceutical care models.

• Pharmaceutical Care
• Interdisciplinary Collaboration
• Patient-Centered Care
• +5 more

Anne G Hoen is an Associate Professor at the Geisel School of Medicine , Dartmouth College, with joint appointments in Epidemiology , Biomedical Data Science , and Microbiology and Immunology . Her research focuses on microbiome development in infants, environmental exposures, and their associations with health outcomes, using interdisciplinary approaches including statistical modeling and bioinformatics. Research Interests: She explores how microbial communities in early life influence disease risk through environmental and dietary factors. Her work integrates microbiome-metabolome interactions, computational methods for microbial network analysis, and epidemiological studies of infectious diseases. Recent Article Trends: 2025-2024 publications highlight maternal diet-microbiome links, microbial interaction networks, ECHO consortium collaborations, and novel computational approaches for microbiome data. Key sub-fields include perinatal exposome, microRNA profiling, and longitudinal metabolomic analysis. Scientific Awards: K01LM011985: Bioinformatics strategies for early life microbiomics R01LM012723: Multi-omic functional integration using networks Advising: Mentors current PhD students in Dartmouth's Quantitative Biomedical Sciences (QBS) program, including Becky Lebeaux and Quang Nguyen, while alumni like Sara Lundgren and Wes Viles hold postdoctoral and academic positions.

• Microbiome research
• Epidemiology
• Environmental health
• +7 more

Michael S.D. Agus, M.D. is the Constantine Anast, MD Professor of Pediatrics at Boston Children's Hospital, which is affiliated with Harvard Medical School. He serves in the Department of Pediatrics with a focus on critical care and endocrinology. Dr. Agus is a prominent researcher in pediatric critical care medicine, with particular expertise in glycemic control, diabetic ketoacidosis, and sepsis management in critically ill children. Dr. Agus's research interests center around optimizing care for critically ill children, with a strong focus on glucose management in pediatric intensive care settings. His work has significantly contributed to understanding the optimal blood glucose ranges for critically ill children, the management of diabetic ketoacidosis in pediatric patients, and the role of corticosteroids in pediatric septic shock. He has led several major NIH-funded clinical trials including the HALF-PINT (Heart and Lung Failure-Pediatric INsulin Titration) trial and the SHIPSS (Stress Hydrocortisone In Pediatric Septic Shock) study. Dr. Agus has been instrumental in developing clinical guidelines for glycemic control in critically ill children, as evidenced by his contributions to the Society of Critical Care Medicine Guidelines. His research employs advanced methodologies including transcriptomics to identify subclasses of pediatric septic shock, potentially enabling more personalized treatment approaches. His work bridges the gap between critical care medicine and endocrinology, focusing on how metabolic management affects outcomes in critically ill children. Dr. Agus has received significant recognition for his research, with numerous high-impact publications in leading medical journals including Critical Care Medicine , Pediatric Critical Care Medicine , and The Lancet Child & Adolescent Health . His work on glycemic control has been particularly influential in shaping clinical practice for critically ill children with diabetes or hyperglycemia. As a principal investigator on multiple NIH grants, Dr. Agus leads a robust research program focused on improving outcomes for critically ill children. His work extends beyond direct patient care to include healthcare systems research, examining optimal staffing models in pediatric intensive care units and building global collaborative research networks in pediatric critical care. He is actively involved in translating research findings into clinical practice through guideline development and educational initiatives.

• Pediatric Critical Care
• Pediatric Endocrinology
• Diabetic Ketoacidosis
• +4 more

Søren Lundbye-Christensen is an Associate Professor and Biostatistician affiliated with the Clinical Institute at the Faculty of Health Sciences, Aalborg University, and Aalborg University Hospital in Denmark. He specializes in biostatistical support for medical research, with a strong emphasis on cardiovascular and epidemiological studies. His research interests include biostatistics, survival analysis, cohort studies, clinical epidemiology, and statistical modeling in public health. He has contributed to a wide array of healthcare research, particularly in cardiovascular diseases, cancer, maternal health, and infectious diseases. His methodological expertise spans time-to-event analysis, registry-based research, and interval-censored data modeling. The recent publications highlight a strong trend in applying advanced statistical methods to large-scale clinical and population-based datasets. His work often involves collaboration with medical researchers to derive prognostic models, validate clinical databases, and assess public health outcomes. Key themes include cardiovascular risk, fertility, cancer biomarkers, and implementation of medical training programs. Scientific Contributions and Recognition: Published over 320 research articles and datasets. Active contributor to methodological advancements in biostatistics. Regular peer reviewer, including for journals like the R Journal. Public engagement through media appearances on statistics and health. Academic Advising and Grants: Søren has supervised 31 student theses, formally serving as PhD supervisor for 14 theses and as a biostatistical advisor for 19 others, primarily in mathematics and statistics. He has participated in numerous research projects funded through institutional and national grants, including studies on seasonal disease trends, postoperative complications, and metabolic disease prediction. His work often involves interdisciplinary collaboration across medicine, public health, and data science. Labs and Research Teams: He is embedded in collaborative research networks at Aalborg University Hospital and Aalborg University, contributing statistical expertise to clinical research groups. He is involved in projects utilizing Danish national health registries and has contributed to the development and validation of clinical databases. His work supports both hypothesis-driven medical research and methodological innovation in biostatistics.

• Biostatistics
• Medical Statistics
• Cardiovascular Research
• +7 more

Shaji K Chacko, Ph.D., is an Instructor in the Department of Pediatrics – Nutrition at Baylor College of Medicine, where he leads an independent research laboratory at the USDA/ARS Children's Nutrition Research Center in Houston, Texas. His work focuses on metabolic regulation, particularly glucose production pathways in health and disease. BS, Nagpur University (1990) MS, Barkatullah University (1992) MS, University of Houston, Clear Lake (2000) PhD, University of Groningen (2011) Dr. Chacko's research centers on glucose metabolism , specifically gluconeogenesis and glycogenolysis , using stable isotope tracers and mass spectrometry. His lab investigates metabolic dysfunctions in conditions such as insulin resistance, type 2 diabetes, and post-surgical states, with a strong focus on pediatric and neonatal populations. He also studies total energy expenditure using the doubly labeled water method in free-living subjects. The 15 most recent publications reflect a consistent focus on metabolic regulation, particularly in insulin resistance , obesity , diabetes , and parenteral nutrition . Key themes include hormonal regulation (e.g., leptin), amino acid metabolism (glycine, BCAA), liver function, and therapeutic interventions like metformin and nutritional supplements. His work frequently involves translational models, including human clinical studies and genetically modified animal models. Dr. Chacko has not received any explicitly mentioned scientific awards in the provided texts. He mentors lab members such as Zhensheng Chen (Research Associate) and collaborates extensively with clinicians and scientists, including M.W. Haymond and F. Jahoor. While no specific grants are listed, his research likely involves externally funded projects given the scope and equipment required for stable isotope and mass spectrometry studies. His lab benefits from the state-of-the-art facilities at the Children's Nutrition Research Center, including a metabolic kitchen, greenhouse, and advanced instrumentation. The Shaji Chacko Lab is embedded within the USDA/ARS Children's Nutrition Research Center, a multidisciplinary hub housing elite scientists conducting cutting-edge research in pediatric nutrition and metabolism. The center provides extensive resources including specialized laboratories, research accommodations, and a collaborative scientific environment.

• Glucose Metabolism
• Gluconeogenesis
• Glycogenolysis
• +12 more

Lindsay Alpert is an Associate Professor in the Department of Pathology at the University of Chicago's Pritzker School of Medicine. As a surgical pathologist specializing in gastrointestinal pathology, Dr. Alpert provides expert diagnostic services for neoplastic and non-neoplastic diseases of the gastrointestinal tract, biliary tree, and pancreas. Dr. Alpert received her MD from Columbia University College of Physicians and Surgeons in 2012. She completed her residency in Anatomic Pathology and fellowship in Gastrointestinal and Hepatic Pathology at the University of Chicago, finishing her fellowship in 2016 and residency in 2017. Dr. Alpert's research focuses on gastrointestinal pathology with particular expertise in inflammatory bowel disease, colorectal carcinoma, and the gut microbiome. Her work examines dysplasia patterns in IBD patients, histologic features of enteropathies, and the impact of therapeutic interventions on gastrointestinal tissues. She has made significant contributions to understanding the histologic spectrum of various gastrointestinal conditions and their clinical implications, with numerous publications in high-impact journals like Modern Pathology and Gastroenterology. Analysis of Dr. Alpert's recent publications reveals a strong focus on gastrointestinal pathology, particularly inflammatory bowel disease and colorectal neoplasia. Her work spans diagnostic pathology, molecular characterization of gastrointestinal tumors, and the impact of therapeutic interventions. Many studies examine dysplasia patterns in IBD patients across different age groups and presentations, while others investigate rare gastrointestinal conditions and their histologic features. Her research often bridges basic science with clinical applications, examining how dietary and pharmacological factors influence gastrointestinal pathology. Dr. Alpert actively collaborates with numerous researchers and clinicians at the University of Chicago and beyond, contributing to multidisciplinary studies that bridge pathology with clinical gastroenterology and oncology. Her network includes prominent colleagues such as John Hart, Namrata Setia, and Shu-Yuan Xiao. Dr. Alpert maintains an active research laboratory focused on gastrointestinal pathology, where she mentors trainees and collaborates with colleagues on various research projects examining the histopathology of gastrointestinal diseases. Her team works closely with clinicians to translate pathological findings into improved diagnostic criteria and patient care, particularly for complex cases involving inflammatory bowel disease and gastrointestinal neoplasia.

• Gastrointestinal Pathology
• Inflammatory Bowel Disease
• Colorectal Carcinoma
• +7 more